Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04083651
Title A Study of Methylnaltrexone Bromide (MNTX) in Participants With Advanced Pancreatic Cancer
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements No
Sponsors Bausch Health Americas, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Bausch Site 001 Omaha Nebraska 68118 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field